The relationship of circulating insulin-like growth factor 1, its binding protein-3, prostate-specific antigen and C-reactive protein with disease stage in prostate cancer

被引:27
作者
Latif, Z
McMillan, DC
Wallace, AM
Sattar, N
Mir, K
Jones, G
Underwood, MA
机构
[1] Univ Glasgow, Royal Infirm, Dept Surg, Glasgow G31 2ER, Lanark, Scotland
[2] Univ Glasgow, Royal Infirm, Dept Biochem, Glasgow G31 2ER, Lanark, Scotland
[3] Univ Glasgow, Royal Infirm, Dept Urol, Glasgow G31 2ER, Lanark, Scotland
关键词
prostate cancer; IGF-1; IGFBP-3; PSA; C-reactive protein;
D O I
10.1046/j.1464-4096.2001.01641.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the relationships among circulating insulin-like growth factor-1 (IGF-1), IGF binding protein-3 (IGFBP-3), prostate-specific antigen (PSA) and C-reactive protein (an indicator of inflammatory systemic response) in patients with prostate disease and cancer of different stages. Patients and methods Circulating IGF-1, IGFBP-3, PSA and C-reactive protein concentrations were measured inpatients with BPH (17) or stages T1/T2 (15). T3/T4 (16) and metastatic prostate cancer (12 patients). Results IGF-1 and IGFBP-3 concentrations were similar between patients with BPH and those with cancer, and there was no difference between the groups with cancer. In the latter patients there was a significant correlation between age and IGFBP-3 concentrations (r = -0.400, P = 0.008) but not with IGF-1 concentrations. Controlling for age, there were significant partial correlations between C-reactive protein and IGF-1 (r = -0.412. P = 0.008) and IGFBP-3 (r = -0.277, P = 0.05). Conclusions These results indicate that circulating IGF-1 and IGFBP-3 concentrations do not change with disease stage in prostate cancer, but that they decrease with an increase In the systemic inflammatory response.
引用
收藏
页码:396 / 399
页数:4
相关论文
共 15 条
[1]   INSULIN-LIKE GROWTH FACTOR-I - A VALID NUTRITIONAL INDICATOR DURING PARENTERAL-FEEDING OF PATIENTS SUFFERING AN ACUTE PHASE RESPONSE [J].
BURGESS, EJ .
ANNALS OF CLINICAL BIOCHEMISTRY, 1992, 29 :137-144
[2]   Serum levels of insulin-like growth factor-1 in the three months following surgery for a hip fracture in elderly: relationship with nutritional status and inflammatory reaction [J].
Campillo, B ;
Paillaud, E ;
Bories, PN ;
Noel, M ;
Porquet, D ;
Le Parco, JC .
CLINICAL NUTRITION, 2000, 19 (05) :349-354
[3]   Plasma insulin-like growth factor I and prostate cancer risk: A prospective study [J].
Chan, JM ;
Stampfer, MJ ;
Giovannucci, E ;
Gann, PH ;
Ma, J ;
Wilkinson, P ;
Hennekens, CH ;
Pollak, M .
SCIENCE, 1998, 279 (5350) :563-566
[4]  
Cutting CWM, 1999, BJU INT, V83, P996
[5]  
DAUGHADAY WH, 1990, ENDOCRINOLOGY, V127, P1
[6]   INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II - PEPTIDE, MESSENGER RIBONUCLEIC-ACID AND GENE STRUCTURES, SERUM, AND TISSUE CONCENTRATIONS [J].
DAUGHADAY, WH ;
ROTWEIN, P .
ENDOCRINE REVIEWS, 1989, 10 (01) :68-91
[7]   SERUM TUMOR-MARKERS IN HUMAN PROSTATIC-CARCINOMA - THE VALUE OF A MARKER PANEL FOR PROGNOSTIC INFORMATION [J].
EKMAN, P ;
LEWENHAUPT, A .
ACTA ONCOLOGICA, 1991, 30 (02) :173-175
[8]   Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation [J].
Heemskerk, VH ;
Daemen, MARC ;
Buurman, WA .
CYTOKINE & GROWTH FACTOR REVIEWS, 1999, 10 (01) :5-14
[9]   The significance of serum levels of insulin-like growth factor-1 in patients with prostate cancer [J].
Kurek, R ;
Tunn, UW ;
Eckart, O ;
Aumüller, G ;
Wong, J ;
Renneberg, H .
BJU INTERNATIONAL, 2000, 85 (01) :125-129
[10]   INSULIN-LIKE GROWTH-FACTORS IN HEALTH AND DISEASE [J].
LEROITH, D ;
CLEMMONS, D ;
NISSLEY, P ;
RECHLER, MM .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (10) :854-862